SARS-CoV-2 is predominantly a respiratory disease that spreads primarily through direct contact (droplets, person to person). However, gastrointestinal (GI) symptoms such as vomiting, nausea, diarrhoea, and abdominal pain are becoming more often recognised as COVID-19 symptoms. Other symptoms of COVID-19, such as dysgeusia and anosmia, have also become more well-known. Studies have also found that these GI symptoms are frequently an early manifestation of Covid-19 and hence a strong predictor of the virus's emergence. There are still many unanswered questions and challenges, such as the relevance of virus detection in asymptomatic subjects' stool/rectal swabs, whether ACE2 is a direct mediator for SARS-CoV-2 entry into the GI tract, and how the virus might survive passage through the digestive system's extreme pH environment. As a result, it's critical to see Covid-19 as more than a respiratory disease and to identify approaches to manage the disease's gastrointestinal component.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Title : The role of G-tube placement for neurologic injury patients
Brandon Lucke Wold, University of Florida, United States
Title : Peptidase inhibitor 3 [PI3) contribution to risk of celiac disease. Functional characterization of polymorphisms in the PI3 gene
Maria Isabel Torres Lopez, University of Jaen, Spain
Title : Menetrier's disease presenting as gastric outlet obstruction mimicking linitis plastica: A case report
Erika Johanna P Tanada, University of Santo Tomas Hospital, Philippines
Title : Endoscopic resection of a granular cell tumor: A case report
Omar Ahmed Alomair, King Faisal University, Saudi Arabia